NEW YORK (GenomeWeb News) - Dionex said today that it has closed its purchase of HPLC products, clinical assays, and lab services from ESA Biosciences' parent company, Magellan Biosciences, in a deal that was struck in mid-September.
Under the deal, Sunnyvale, Calif.-based Dionex will gain three lines of HPLC detectors. These products include the Corona Universal Charged Aerosol Detectors, which Dionex will sell with its own HPLC equipment or directly on third party systems. The other two product lines, the CoulArray and Coulocheme electrochemical detectors are targeted at clinical, metabolomics, and neuroscience applications.
Financial terms of the agreement were not released.